QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations
Clinical trial NCT06715124 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06715124
- Sponsor
- Quanta Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-14
- Primary completion
- 2027-01-02
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.